N
CDLX icon

Nuveen’s Cardlytics CDLX Stock Holding History

Nuveen’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,620
Closed -$302K – 3293
2025
Q1 		$302K Hold
16,620
– – ﹤0.01% 3041
2024
Q4 		$617K Hold
16,620
– – ﹤0.01% 2910
2024
Q3 		$532K Sell
16,620
-49,926
-75% -$2.77M ﹤0.01% 2998
2024
Q2 		$5.46M Buy
66,546
+13,251
+25% +$1.43M ﹤0.01% 1904
2024
Q1 		$7.72M Buy
53,295
+1,221
+2% +$103K ﹤0.01% 1756
2023
Q4 		$4.8M Buy
52,074
+3,875
+8% +$394K ﹤0.01% 2004
2023
Q3 		$7.95M Buy
48,199
+46,054
+2,147% +$5.98M ﹤0.01% 1609
2023
Q2 		$136K Sell
2,145
-7,230
-77% -$438K ﹤0.01% 3138
2023
Q1 		$318K Sell
9,375
-15,212
-62% -$795K ﹤0.01% 2904
2022
Q4 		$1.42M Buy
24,587
+11,147
+83% +$689K ﹤0.01% 2524
2022
Q3 		$1.26M Buy
13,440
+323
+2% +$46K ﹤0.01% 2642
2022
Q2 		$2.93M Buy
13,117
+2,347
+22% +$786K ﹤0.01% 2240
2022
Q1 		$6.09M Sell
10,770
-3,021
-22% -$1.83M ﹤0.01% 1958
2021
Q4 		$9.11M Sell
13,791
-3,025
-18% -$2.31M ﹤0.01% 1751
2021
Q3 		$14.1M Sell
16,816
-2,381
-12% -$2.42M ﹤0.01% 1530
2021
Q2 		$24.4M Buy
19,197
+1,350
+8% +$1.52M 0.01% 1207
2021
Q1 		$19.6M Buy
17,847
+2,462
+16% +$3.25M 0.01% 1338
2020
Q4 		$22M Buy
15,385
+2,407
+19% +$2.57M 0.01% 1199
2020
Q3 		$9.16M Sell
12,978
-11,843
-48% -$8.61M ﹤0.01% 1576
2020
Q2 		$17.4M Buy
24,821
+7,814
+46% +$4.51M 0.01% 1137
2020
Q1 		$5.95M Sell
17,007
-5,675
-25% -$4.02M ﹤0.01% 1608
2019
Q4 		$14.3M Buy
22,682
+17,279
+320% +$8.45M 0.01% 1373
2019
Q3 		$1.81M Sell
5,403
-59
-1% -$18.9K ﹤0.01% 2445
2019
Q2 		$1.42M Buy
+5,462
New +$1.09M ﹤0.01% 2591

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Nuveen's CDLX Position: Q2 2025 in Review

Nuveen sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 16,620 shares — an estimated $302K sold.

Nuveen first reported a position in CDLX in Q2 2019 and held it in 24 quarters. The position peaked at $24.4M in Q2 2021. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • Nuveen reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 16,620 Cardlytics shares in Q2 2025, an estimated $302K.
  • Nuveen first reported a position in Cardlytics in Q2 2019 and held it in 24 quarters.
  • Nuveen's Cardlytics position peaked at $24.4M in Q2 2021.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.